Version 5.4
Bos taurus Protein: BT.55630
Summary
InnateDB Protein IDBP-681776.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BT.55630
Protein Name melanoma inhibitory activity protein 3
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000025055
InnateDB Gene IDBG-630292 (BT.55630)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
Predicted by orthology
Total 2 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
Biological Process
GO:0002063 chondrocyte development
GO:0002687 positive regulation of leukocyte migration
GO:0006887 exocytosis
GO:0007162 negative regulation of cell adhesion
GO:0015031 protein transport
GO:0030199 collagen fibril organization
GO:0030336 negative regulation of cell migration
GO:0030501 positive regulation of bone mineralization
GO:0042060 wound healing
Cellular Component
GO:0005789 endoplasmic reticulum membrane
GO:0016020 membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro IPR001452 SH3 domain
IPR011511 Variant SH3 domain
PFAM PF00018
PF14604
PF07653
PRINTS PR00452
PIRSF
SMART SM00326
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL G5E5L5
UniProt Splice Variant
Entrez Gene 509133
UniGene Bt.55630
RefSeq NP_001160043
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02042618
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca